EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow.
Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseases may cause anemia. To curb rising incidence of anemia, demand for erythropoietin drugs is expected to increase over the coming years.
The global Erythropoietin (EPO) Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erythropoietin (EPO) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin (EPO) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application
Anemia
Kidney Disorders
Other
Table of Contents
Executive Summary
1 Erythropoietin (EPO) Drugs Market Overview
1.1 Product Overview and Scope of Erythropoietin (EPO) Drugs
1.2 Erythropoietin (EPO) Drugs Segment by Type
1.2.1 Global Erythropoietin (EPO) Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Erythropoietin (EPO) Drugs Segment by Application
1.3.1 Erythropoietin (EPO) Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.3 Global Erythropoietin (EPO) Drugs Market by Region
1.3.1 Global Erythropoietin (EPO) Drugs Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Erythropoietin (EPO) Drugs Market Size
1.4.1 Global Erythropoietin (EPO) Drugs Revenue (2014-2025)
1.4.2 Global Erythropoietin (EPO) Drugs Production (2014-2025)
2 Global Erythropoietin (EPO) Drugs Market Competition by Manufacturers
2.1 Global Erythropoietin (EPO) Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Erythropoietin (EPO) Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Erythropoietin (EPO) Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Erythropoietin (EPO) Drugs Production Sites, Area Served, Product Types
2.5 Erythropoietin (EPO) Drugs Market Competitive Situation and Trends
2.5.1 Erythropoietin (EPO) Drugs Market Concentration Rate
2.5.2 Erythropoietin (EPO) Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Erythropoietin (EPO) Drugs Production Market Share by Regions
3.1 Global Erythropoietin (EPO) Drugs Production Market Share by Regions
3.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Erythropoietin (EPO) Drugs Production
3.4.1 North America Erythropoietin (EPO) Drugs Production Growth Rate (2014-2019)
3.4.2 North America Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Erythropoietin (EPO) Drugs Production
3.5.1 Europe Erythropoietin (EPO) Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Erythropoietin (EPO) Drugs Production (2014-2019)
3.6.1 China Erythropoietin (EPO) Drugs Production Growth Rate (2014-2019)
3.6.2 China Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Erythropoietin (EPO) Drugs Production (2014-2019)
3.7.1 Japan Erythropoietin (EPO) Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Erythropoietin (EPO) Drugs Consumption by Regions
4.1 Global Erythropoietin (EPO) Drugs Consumption by Regions
4.2 North America Erythropoietin (EPO) Drugs Consumption (2014-2019)
4.3 Europe Erythropoietin (EPO) Drugs Consumption (2014-2019)
4.4 China Erythropoietin (EPO) Drugs Consumption (2014-2019)
4.5 Japan Erythropoietin (EPO) Drugs Consumption (2014-2019)
5 Global Erythropoietin (EPO) Drugs Production, Revenue, Price Trend by Type
5.1 Global Erythropoietin (EPO) Drugs Production Market Share by Type (2014-2019)
5.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Erythropoietin (EPO) Drugs Price by Type (2014-2019)
5.4 Global Erythropoietin (EPO) Drugs Production Growth by Type (2014-2019)
6 Global Erythropoietin (EPO) Drugs Market Analysis by Applications
6.1 Global Erythropoietin (EPO) Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Erythropoietin (EPO) Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Erythropoietin (EPO) Drugs Business
7.1 Amgen
7.1.1 Amgen Erythropoietin (EPO) Drugs Production Sites and Area Served
7.1.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.1.3 Amgen Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Erythropoietin (EPO) Drugs Production Sites and Area Served
7.2.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.2.3 Johnson & Johnson Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Roche
7.3.1 Roche Erythropoietin (EPO) Drugs Production Sites and Area Served
7.3.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.3.3 Roche Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Galenica
7.4.1 Galenica Erythropoietin (EPO) Drugs Production Sites and Area Served
7.4.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.4.3 Galenica Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Emcure
7.5.1 Emcure Erythropoietin (EPO) Drugs Production Sites and Area Served
7.5.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.5.3 Emcure Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Kyowa Hakko Kirin
7.6.1 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Production Sites and Area Served
7.6.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 3SBio
7.7.1 3SBio Erythropoietin (EPO) Drugs Production Sites and Area Served
7.7.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.7.3 3SBio Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Biocon
7.8.1 Biocon Erythropoietin (EPO) Drugs Production Sites and Area Served
7.8.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.8.3 Biocon Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 LG Life Sciences
7.9.1 LG Life Sciences Erythropoietin (EPO) Drugs Production Sites and Area Served
7.9.2 Erythropoietin (EPO) Drugs Product Introduction, Application and Specification
7.9.3 LG Life Sciences Erythropoietin (EPO) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
8 Erythropoietin (EPO) Drugs Manufacturing Cost Analysis
8.1 Erythropoietin (EPO) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Erythropoietin (EPO) Drugs
8.4 Erythropoietin (EPO) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Erythropoietin (EPO) Drugs Distributors List
9.3 Erythropoietin (EPO) Drugs Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Erythropoietin (EPO) Drugs Market Forecast
11.1 Global Erythropoietin (EPO) Drugs Production, Revenue Forecast
11.1.1 Global Erythropoietin (EPO) Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Erythropoietin (EPO) Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Erythropoietin (EPO) Drugs Price and Trend Forecast (2019-2025)
11.2 Global Erythropoietin (EPO) Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Erythropoietin (EPO) Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Erythropoietin (EPO) Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Erythropoietin (EPO) Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Erythropoietin (EPO) Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Erythropoietin (EPO) Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Erythropoietin (EPO) Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Erythropoietin (EPO) Drugs Consumption Forecast (2019-2025)
11.3.3 China Erythropoietin (EPO) Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Erythropoietin (EPO) Drugs Consumption Forecast (2019-2025)
11.4 Global Erythropoietin (EPO) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Erythropoietin (EPO) Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
